Skip to main content
Home logo

User account menu

Log inSearch

Main navigation

  • Home
  • Data Sources
  • Studies
  • Institutions
  • Networks
  • What's new
  • Support
  1. Home

Non-Interventional Post-Authorisation Study to Evaluate the Safety, Tolerability and Effectiveness of Berotralstat for Patients with Hereditary Angioedema (HAE) in a Real-World Setting (APeX-N)

08/10/2021
16/07/2024
EU PAS number:
EUPAS43575
Study
Ongoing
Subscribe
Download as PDF

Secondary tabs

Administrative detailsMethodological aspectsData managementResources

Page content

  • Documents
  • Publications
  • ENCePP Seal
Documents
Study protocol
Updated protocol

BCX7353-401 Protocol v3.0_Redacted_10 Jul 2024.pdf

First published: 16/07/2024
English (11.17 MB - PDF)View document
Study results
Study report
Other information
Publications
Study publications
Lee A. Berotralstat: First Approval. Drugs. 2021 Feb;81:405-9.
Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary …
Longhurst H, Cicardi M. Hereditary angio-oedema. The Lancet. 2012 Feb 4;379(981…
Aygören-Pürsün E, Bygum A, Grivcheva-Panovska V, Magerl M, Graff J, Steiner UC,…
Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. The humanis…

Share this page

HMA-EMA Catalogues of real-world data sources and studies

Privacy

Privacy policy
Cookies
Legal notice

Contact

Contact us